Congenica Selected to Provide Diagnostic Decision Support for UK’s Genomic Medicine Service
Genomics England names Congenica as its clinical decision support service partner for the delivery of the NHS genomic medicine service.
Read MorePosted by Steve Halasey | Nov 28, 2018 | Cancer |
Genomics England names Congenica as its clinical decision support service partner for the delivery of the NHS genomic medicine service.
Read MorePosted by Steve Halasey | Nov 27, 2018 | Storage |
The Lantern Project will expand access to free diagnostic genetic testing for a number of lysosomal storage disorders, for which tens of thousands go undiagnosed.
Read MorePosted by Steve Halasey | Nov 27, 2018 | Breast, Molecular Diagnostics |
Healthcare professionals can use the BRACAnalysis CDx assay to identify patients with HER2-negative metastatic breast cancer who have a germline BRCA mutation and are eligible for treatment with Pfizer’s Talzenna.
Read MorePosted by Steve Halasey | Nov 20, 2018 | Controls, Hematology & Serology, Software, Transfusion & Transplantation Tests |
The molecular test is the first of its type approved to report genotypes as final results.
Read MorePosted by Steve Halasey | Nov 20, 2018 | Research |
A study based on OptumInsight data showed more than $6000 in savings in first-year healthcare costs compared to treatment-as-usual for patients with depression.
Read More